期刊
CELL DEATH & DISEASE
卷 13, 期 9, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41419-022-05262-1
关键词
-
类别
资金
- Atidim fellowship
- ICRF 2017 personal grant
- Flinkman Marandi Cancer Research Grant
- German Israeli Foundation [1431]
- German Cancer Aid [DKH 70114554]
- German Research Foundation [DFG GRK2243]
This study reveals that the RNF4-BMP6-RGMb axis plays a crucial role in the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) and is also involved in tumorigenesis.
Molecular understanding of osteogenic differentiation (OD) of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for regenerative medicine and has direct implications for cancer. We report that the RNF4 ubiquitin ligase is essential for OD of hBMSCs, and that RNF4-deficient hBMSCs remain as stalled progenitors. Remarkably, incubation of RNF4-deficient hBMSCs in conditioned media of differentiating hBMSCs restored OD. Transcriptional analysis of RNF4-dependent gene signatures identified two secreted factors that act downstream of RNF4 promoting OD: (1) BMP6 and (2) the BMP6 co-receptor, RGMb (Dragon). Indeed, knockdown of either RGMb or BMP6 in hBMSCs halted OD, while only the combined co-addition of purified RGMb and BMP6 proteins to RNF4-deficient hBMSCs fully restored OD. Moreover, we found that the RNF4-RGMb-BMP6 axis is essential for survival and tumorigenicity of osteosarcoma and therapy-resistant melanoma cells. Importantly, patient-derived sarcomas such as osteosarcoma, Ewing sarcoma, liposarcomas, and leiomyosarcomas exhibit high levels of RNF4 and BMP6, which are associated with reduced patient survival. Overall, we discovered that the RNF4 similar to BMP6 similar to RGMb axis is required for both OD and tumorigenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据